Emily Hunt
Psychiatric/Mental Health · New York, NYNPI 1992316160
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 255 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,855 and has fallen 98.0% since, to $57 in 2023. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 255 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$824
- Teva Pharmaceuticals USA, Inc.$656
- Alkermes, Inc.$472
- Otsuka America Pharmaceutical, Inc.$402
- Bausch Health US, LLC$381
- Takeda Pharmaceuticals U.S.A., Inc.$380
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,30199%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $824 |
| Teva Pharmaceuticals USA, Inc. | 26 | $656 |
| Alkermes, Inc. | 18 | $472 |
| Otsuka America Pharmaceutical, Inc. | 21 | $402 |
| Bausch Health US, LLC | 22 | $381 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $380 |
| Vanda Pharmaceuticals Inc. | 16 | $354 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $348 |
| Sunovion Pharmaceuticals Inc. | 13 | $305 |
| Jazz Pharmaceuticals Inc. | 16 | $304 |
| Neurocrine Biosciences, Inc. | 12 | $190 |
| Merck | 7 | $130 |
| Supernus Pharmaceuticals, Inc. | 9 | $119 |
| Eisai Inc. | 7 | $111 |
| Almatica Pharma LLC | 6 | $98 |
| Johnson & Johnson | 3 | $64 |
| Tris Pharma Inc | 1 | $44 |
| Corium, LLC | 2 | $38 |
| Lundbeck LLC | 2 | $35 |
| Ironshore Pharmaceuticals Inc. | 2 | $31 |
| Alfasigma USA, Inc. | 1 | $22 |
| Acadia Pharmaceuticals Inc | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Neuronetics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,348 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam ErAlprazolam | 12 | $205 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in New York
- Richard CalladoNew York$47K
- Darcy LeonNew York$37K
- Angela AnukamNew York$11K
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.